Randomized clinical trials in oncology commentary.
In this article the author addresses the major questions and problems that arrise while analyzing randomized clinical trials. A brief description is given of three problems, which are how to bring the derived information into broad applicability, when are the results of a trial significant enough to make it a standard for care and the issue of quality control.